ArticleNeuro-oncology2024

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma.

Andrew E Sloan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.